MI
Milestone Pharmaceuticals Inc.
MIST · NASDAQ
$0.93 -4.36% (-$0.04)
1M -13.69%
Market Cap $115.5M
P/E Ratio -
Div. Yield -
ROE 288.36%
Bulios Fair Price
$0.79
14.8% downside
Current Price
$0.93
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MIST is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
11 /100
Expensive P/S 49.29x
P/B 6.34x
P/E N/A
Growth
0 /100
Declining Rev. growth 32.38%
Book val. growth 14.29%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 94.58%
Net margin 3,585.62%
Op. margin 3,353.01%
Quality
0 /100
Poor ROIC 48.96%
ROE 288.36%
ROA 46.26%
Debt
23 /100
High Debt/Equity 3.30x
Current ratio 8.13x
Int. coverage -6.79x
Stability
59 /100
Moderate Beta 0.98x
EPS volatility 34.50%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MIST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph G. Oliveto
Employees
38
Headquarters
Montreal
Upcoming events
11 NOV
Earnings
Upcoming earnings report